Drug class
Long-acting granulocyte colony-stimulating factor (G-CSF); immunostimulant
Mechanism of action
A glycoPEGylated G-CSF analogue that binds G-CSF receptors on haematopoietic cells, stimulating neutrophil precursor proliferation and differentiation and supporting neutrophil recovery.
General use cases
- Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients receiving cytotoxic chemotherapy for malignancy, under the authorised product indication.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
